SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Mowi ASA (MHGVY) trades at a trailing P/E of 17.0, forward P/E of 15.8. Trailing earnings yield is 5.90%, forward earnings yield 6.35%. PEG 0.37 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (17.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.37); earnings yield beats bond yields (5.90%).
- Forward P/E 15.8 (down from trailing 17.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.37 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.90% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.35% as earnings recover.
Overall SharesGrow Score: 76/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MHGVY
Valuation Multiples
P/E (TTM)17.0
Forward P/E15.8
PEG Ratio0.37
Forward PEG2.05
P/B Ratio0.00
P/S Ratio2.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.33
Forward EPS (Est.)$1.43
Book Value / Share$0.00
Revenue / Share$10.50
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.90%
Forward Earnings Yield6.35%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.20 |
$3.5B |
$539.6M |
15.4% |
| 2017 |
$0.86 |
$3.63B |
$462.5M |
12.8% |
| 2018 |
$1.15 |
$3.75B |
$566.6M |
15.1% |
| 2019 |
$0.92 |
$4.07B |
$477.6M |
11.7% |
| 2020 |
$0.23 |
$3.73B |
$117.5M |
3.1% |
| 2021 |
$0.96 |
$4.17B |
$487.6M |
11.7% |
| 2022 |
$1.46 |
$4.91B |
$782.4M |
15.9% |
| 2023 |
$0.86 |
$5.51B |
$444.4M |
8.1% |
| 2024 |
$0.91 |
$5.6B |
$468.5M |
8.4% |
| 2025 |
$1.33 |
$5.46B |
$717.9M |
13.1% |
